山东药玻
(600529)
| 流通市值：146.13亿 | | | 总市值：146.13亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,142,713,713.77 | 1,065,491,481.42 | 1,087,938,009.78 | 1,314,607,277.82 |
| 应收票据及应收账款 | 1,684,803,773.56 | 1,684,244,561.12 | 1,770,483,575.04 | 1,751,975,861.53 |
| 其中：应收票据 | 668,178,885.63 | 729,525,005.96 | 782,719,435.23 | 780,677,502.44 |
| 应收账款 | 1,016,624,887.93 | 954,719,555.16 | 987,764,139.81 | 971,298,359.09 |
| 应收款项融资 | 38,092,118.79 | 47,485,298.8 | 65,422,809.9 | 49,233,635.54 |
| 预付款项 | 144,985,291.24 | 159,356,027.51 | 96,747,719.63 | 79,446,629.08 |
| 其他应收款合计 | 2,450,040.67 | 1,871,612.03 | 1,781,301.28 | 1,839,547.03 |
| 存货 | 1,426,959,581.07 | 1,278,683,724.8 | 1,206,411,867.83 | 1,080,920,893.91 |
| 其他流动资产 | 503,154.79 | 18,635,867.83 | 10,143,689.61 | 7,316,522.34 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,054,844,132.51 | 5,980,458,741.73 | 5,945,154,109.56 | 5,971,975,690 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 50,000 | 50,000 | 50,000 | 50,000 |
| 固定资产 | 3,495,211,844.58 | 3,570,709,084.99 | 3,473,295,662.24 | 3,357,723,071.1 |
| 在建工程 | 229,592,272.55 | 215,358,856.43 | 244,644,403.15 | 227,863,464.65 |
| 无形资产 | 245,560,312.41 | 247,243,260.79 | 248,926,209.12 | 250,609,157.46 |
| 递延所得税资产 | 78,628,035.66 | 74,455,091.84 | 38,584,162.34 | 38,806,348.14 |
| 其他非流动资产 | 69,479,223.91 | 51,734,330.06 | 28,353,249.49 | 44,145,318.92 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,118,521,689.11 | 4,159,550,624.11 | 4,033,853,686.34 | 3,919,197,360.27 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,173,365,821.62 | 10,140,009,365.84 | 9,979,007,795.9 | 9,891,173,050.27 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 1,417,484,756.52 | 1,582,777,149.64 | 1,472,343,971.03 | 1,408,050,294.73 |
| 其中：应付票据 | 641,009,006.47 | 679,183,105.56 | 677,397,525.41 | 649,070,712.17 |
| 应付账款 | 776,475,750.05 | 903,594,044.08 | 794,946,445.62 | 758,979,582.56 |
| 合同负债 | 56,171,516.86 | 60,004,869.36 | 58,949,539.95 | 59,790,198.18 |
| 应付职工薪酬 | 62,587,181.61 | 70,457,876.82 | 71,829,102.22 | 73,346,159.29 |
| 应交税费 | 58,536,479.3 | 50,895,600.5 | 47,837,415.99 | 47,778,921.26 |
| 其他应付款合计 | 168,516,859.34 | 161,997,173.52 | 365,772,222.15 | 426,926,826.61 |
| 应付股利 | - | - | 199,084,233.9 | 265,445,645.2 |
| 其他流动负债 | 50,332,119.4 | 74,434,497.32 | 63,976,929.83 | 62,239,266.8 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,813,628,913.03 | 2,000,567,167.16 | 2,080,709,181.17 | 2,078,131,666.87 |
| 非流动负债: | | | | |
| 递延收益 | 129,451,043.52 | 131,672,508.13 | 110,700,597.67 | 70,732,696.84 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 129,451,043.52 | 131,672,508.13 | 110,700,597.67 | 70,732,696.84 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,943,079,956.55 | 2,132,239,675.29 | 2,191,409,778.84 | 2,148,864,363.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 663,614,113 | 663,614,113 | 663,614,113 | 663,614,113 |
| 资本公积 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 |
| 专项储备 | 65,278,973.36 | 66,392,233.72 | 68,780,718.98 | 69,671,657.64 |
| 盈余公积 | 615,241,973.5 | 615,241,973.5 | 534,179,562.73 | 534,179,562.73 |
| 未分配利润 | 4,199,030,283.92 | 3,975,400,849.04 | 3,833,903,101.06 | 3,787,722,831.9 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 8,230,285,865.07 | 8,007,769,690.55 | 7,787,598,017.06 | 7,742,308,686.56 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 8,230,285,865.07 | 8,007,769,690.55 | 7,787,598,017.06 | 7,742,308,686.56 |
| 负债和股东权益合计 | 10,173,365,821.62 | 10,140,009,365.84 | 9,979,007,795.9 | 9,891,173,050.27 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-29 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |